Books+ Search Results
Lowering the cost of prescription drugs : reducing barriers to market competition : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, March 13, 2019
Author
Title
Lowering the cost of prescription drugs : reducing barriers to market competition : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, March 13, 2019.
Publication
Washington : U.S. Government Publishing Office, 2021.
Physical Description
vi, 246 pages ; 24 cm
Notes
"Serial no. 116-17."
Shipping list no.: 2021-0165-P.
Date of hearing: 2019-03-13.
Other formats
Online version: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. Lowering the cost of prescription drugs
Format
Books
Language
English
Added to Catalog
December 14, 2021
Performers
Hearing witnesses: Lou Kennedy, Chief Executive Officer and Owner, Nephron Pharmaceuticals; Chester "Chip'' Davis, Jr., President and Chief Executive Officer, Association for Accessible Medicines; Anthony A. Barrueta, Senior Vice President, Government Relations, Kaiser Permanente; Marc M. Boutin, Chief Executive Officer, National Health Council; Kurt R. Karst, Director, Hyman, Phelps and McNamara, P. C; Jeffrey P. Kushan, Partner, Sidley Austin, LLP; Michael A. Carrier, Distinguished Professor, Rutgers Law School.
Bibliography
Includes bibliographical references.
Subjects
Genre/Form
Legislative hearings.
Patents.
Legislative hearings.
Bookmark As
Citation
